AI assistant
NextTrip, Inc. — Proxy Solicitation & Information Statement 2020
Mar 25, 2020
34837_rns_2020-03-25_b22dc8bf-08c3-47bd-99a6-fa25dd090d05.zip
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
DEFA14A 1 defa14a.htm
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
| [ ] | Preliminary
Proxy Statement |
| --- | --- |
| [ ] | Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| [ ] | Definitive
Proxy Statement |
| [X] | Definitive
Additional Materials |
| [ ] | Soliciting
Material Pursuant to §240.14a-12 |
SIGMA LABS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (check the appropriate box);
| [X] | No
fee required. |
| --- | --- |
| [ ] | Fee
computed on table below per Exchange Act Rules 14a(i)(1) and 0-11. |
| (1) | Title
of each class of securities to which transaction applies: |
| --- | --- |
| (2) | Aggregate
number of securities to which transaction applies: |
| (3) | Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined): |
| (4) | Proposed
maximum aggregate value of transaction: |
| (5) | Total
fee paid: |
| [ ] | Fee
paid previously with preliminary materials. |
| --- | --- |
| [ ] | Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date
of its filing. |
| (1) | Amount
Previously Paid: |
| --- | --- |
| (2) | Form,
Schedule or Registration Statement No.: |
| (3) | Filing
Party: |
| (4) | Date
Filed: |
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
SIGMA LABS, INC.
3900 Paseo del Sol
Santa Fe, New Mexico 87507
ADDITIONAL INFORMATION REGARDING THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON FRIDAY, MARCH 27, 2020
The following Notice of Change of Location relates to the proxy statement (the “Proxy Statement”) of Sigma Labs, Inc. (the “Company”), dated March 2, 2020, furnished to shareholders of the Company in connection with the solicitation of proxies by the Board of Directors of the Company for use at the Special Meeting of Stockholders (the “Special Meeting”) to be held on Friday, March 27, 2020. This Supplement is being filed with the Securities and Exchange Commission and is being made available to stockholders on or about March 25, 2020.
As described in the proxy materials for the Special Meeting previously distributed, you are entitled to participate in the Special Meeting if you were a stockholder as of the close of business on February 18, 2020, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee.
THE NOTICE SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT.
Field: Rule-Page
Field: /Rule-Page
NOTICE OF CHANGE OF LOCATION
OF SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON MARCH 27, 2020
Sigma Labs Announces Virtual Format Change for 2020 Special Meeting of Stockholders
Special Meeting of Stockholders Shifted to Virtual Format Due to COVID-19 Pandemic Related Health Concerns
SANTA FE, NM - March 25, 2020 - Sigma Labs, Inc. (NASDAQ: SGLB) (“Sigma Labs” or the “Company”), a leading developer of quality assurance software for the commercial 3D printing industry, announced today that, due to the current situation regarding the public health impact of the COVID-19 pandemic and limitations within the state of New Mexico on all non-essential gatherings of individuals, the Company has changed the format of its special stockholders meeting from a physical in-person meeting to a virtual webcast, and invites stockholders to participate remotely.
The special stockholders meeting will be held at 10:00 a.m. Mountain time on March 27, 2020 via webcast.
Field: Page; Sequence: 2; Options: NewSection; Value: 2
2
Field: /Page
Please see below for full details:
Sigma Labs Virtual Special Stockholders Meeting
| Date: | March
27, 2020 |
| --- | --- |
| Time: | 10:00
a.m. Mountain time |
| Webcast
Link: | www.viewproxy.com/SigmaLabsInc/2020SM/vm/ |
Attending the Virtual Special Meeting
Both stockholders of record and stockholders who hold their shares in “street name” will need to register to be able to attend the Special Meeting via live audio webcast, submit their questions during the meeting and vote their shares electronically at the Special Meeting by following the instructions below.
If you are a stockholder of record, you must:
● First register at http://www.viewproxy.com/SigmaLabsInc/2020SM by 11:59 p.m. (EDT) on March 26 2020. You will need to enter your name, phone number, virtual control number (included on your proxy card) and email address as part of the registration, following which, you will receive an email confirming your registration, as well as the password to attend the Special Meeting.
● On the day of the Special Meeting, if you have properly registered, you may enter the Special Meeting by logging in using the password you received via email in your registration confirmation at http://www.viewproxy.com/SigmaLabsInc/2020SM/vm/ (you will need the virtual control number included on your proxy card).
● If you wish to vote your shares electronically at the Special Meeting, you will need to visit www.AALvote.com/sglbsm during the Special Meeting while the polls are open (you will need the virtual control number included on your proxy card).
If your shares are held in a “street name,” you must:
● Obtain a legal proxy from your broker, bank or other nominee.
● Register at http://www.viewproxy.com/SigmaLabsInc/2020SM by 11:59 p.m. (EDT) on March 26, 2020.
You will need to enter your name, phone number and email address, and provide a copy of the legal proxy (which may be uploaded to the registration website or sent via [email protected] as part of the registration, following which, you will receive an email confirming your registration, your virtual control number, as well as the password to attend the Special Meeting.
Please note, if you do not provide a copy of the legal proxy, you may still attend the Special Meeting but you will be unable to vote your shares electronically at the Special Meeting.
● On the day of the Special Meeting, if you have properly registered, you may enter the Special Meeting by logging in using the password you received via email in your registration confirmation at http://www.viewproxy.com/SigmaLabsInc/2020SM/vm/ (you will need the virtual control number assigned to you in your registration confirmation email).
● If you wish to vote your shares electronically at the Special Meeting, you will need to visit www.AALvote.com/sglbsm during the Special Meeting while the polls are open (you will need the virtual control number assigned to you in your registration confirmation email).
Field: Page; Sequence: 3; Value: 2
3
Field: /Page
Technical Difficulties
We will have technicians ready to assist you with any technical difficulties you may have accessing the Special Meeting live audio webcast. Please be sure to check in by 9:30 a.m. (MDT) on March 27, 2020, the day of the Special Meeting, so we may address any technical difficulties before the Special Meeting live audio webcast begins. If you encounter any difficulties accessing the Special Meeting live audio webcast during the check-in or meeting time, please email [email protected] or call 866-612-8937
About Sigma Labs
Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D® brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (CAI) solutions known as PrintRite3D® for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.sigmalabsinc.com .
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Annual Report on Form 10-K (including but not limited to the discussion under “Risk Factors” therein) filed with the SEC on March 24, 2020 and which may be viewed at www.sec.gov .
Investor Contact:
Chris Tyson Managing Director MZ Group - MZ North America 949-491-8235 [email protected] www.mzgroup.us
By Order of the Board of Directors,
| /s/
John Rice |
| --- |
| John
Rice |
| Chief
Executive Officer |
March 25, 2020
The proxy statement is available on our Investor Relations website at https://ir.sigmalabsinc.com/sec-filings . Additionally, you may access our proxy materials at http://www.viewproxy.com/sigmalabsinc/2020SM
Field: Page; Sequence: 4; Value: 2
4
Field: /Page